Biosimilars - MM+M - Medical Marketing and Media

Biosimilars

All articles by Biosimilars

Coronavirus isn’t the only thing on FDA’s mind
Coronavirus isn’t the only thing on FDA’s mind
Alison Kanski
April 1, 2020
5:00 am

Drugs are still being approved and reports are still churning out, all while the FDA battles the COVID-19 outbreak.

FDA clarifies biosimilar labeling, advertising guidelines
FDA clarifies biosimilar labeling, advertising guidelines
Alison Kanski
February 5, 2020
5:00 am

The FDA and FTC want to ensure companies don’t use anticompetitive practices to squash the biosimilar market.

Infographic | Global medicine spending predictions
Infographic | Global medicine spending predictions
MMM Staff
March 4, 2019
5:00 am

A recent IQVIA report breaks down global medicine spending and eyes what lies ahead.

The next five years of pharma: Pricing, biosimilars, and specialty medicines
The next five years of pharma: Pricing, biosimilars, and specialty medicines
Alison Kanski
January 29, 2019
10:11 am

A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.

Pfizer lawsuit could clear path for biosimilars
Pfizer lawsuit could clear path for biosimilars
Alison Kanski
August 23, 2018
5:00 pm

Biosimilars have only been in the market for three years, but they have struggled to compete with their branded equivalents.

Sandoz lines up potential third-to-market Humira copy
Sandoz lines up potential third-to-market Humira copy
Laura Entis
January 17, 2018
3:00 pm

Although if approved, it’s not likely to launch in the U.S. for quite some time.

Five things for pharma marketers to know: Wednesday, January 10, 2018
Five things for pharma marketers to know: Wednesday, January 10, 2018
Virginia Lau
January 10, 2018
3:10 pm

Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict

Five things for pharma marketers to know: Wednesday, December 20, 2017
Five things for pharma marketers to know: Wednesday, December 20, 2017
Virginia Lau
December 20, 2017
2:20 pm

Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease

Five things for pharma marketers to know: Wednesday, November 22, 2017
Five things for pharma marketers to know: Wednesday, November 22, 2017
November 22, 2017
3:49 pm

WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium’s Xtampza over Purdue’s OxyContin

Five things for pharma marketers to know: Wednesday, November 15, 2017
Five things for pharma marketers to know: Wednesday, November 15, 2017
Kevin McCaffrey
November 15, 2017
3:13 pm

FDA approves AstraZeneca asthma drug; Senate tax reform bill would repeal Obamacare mandate; J&J drops Remicade biosimilar lawsuit

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners